INS and Hypoglycemia: In insulin-deficient patients, ABA supplementation should improve and prolong the action of exogenous insulin, perhaps allowing them to reduce their daily dose of insulin (and the risk of hypoglycemia), while at the same time ameliorating glycemic control.